While the mechanisms remain unclear, lower levels of complexin-II (but not complexin-I) have been shown to associate with autopsy-assessed cortical atrophy, a link that may be mediated by other non-AD processes (27). This evidence concerns the gene CPLX1 and Alzheimer disease.